We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Smith & Nephew

Manufactures medical products and devices in the fields of Orthopaedic Reconstruction (joint replacement systems for ... read more Featured Products: More products

Download Mobile App




Tibia Nailing System with Novel Side-Specific Nails to Revolutionize Fracture Surgery

By HospiMedica International staff writers
Posted on 25 Jun 2025

Smith+Nephew (Hull, UK;) has launched its new TRIGEN MAX Tibia Nailing System for stable and unstable fractures of the tibia, including the shaft. More...

It is the only system to now offer trauma surgeons the choice of side-specific (right and left) nails for anatomic screw trajectories, which help to optimize fragment fixation and minimize soft tissue irritation with headless and low-profile screw options.

The TRIGEN MAX Tibia Nailing System aims to streamline operative procedures and provide efficiency through surgeon-centered design of components and instrumentation. These include a two-piece modular drop system to help when using ancillary instruments and aid visualization; a 12.5mm channel reamer for the tibia which is designed to preserve the integrity of the entry point and provide soft tissue protection; and 5.0mm Lag Screws that compress the fracture in one screw insertion step, creating a streamlined workflow. Smith+Nephew’s family of TRIGEN Nails has delivered proven performance and industry-leading design for more than two decades. The new TRIGEN MAX Tibia Nailing System is poised to be the next flagship product, setting the standard of care and performance for intramedullary nails.

“By focusing on both implant innovation and instrumentation, we’re delivering a smarter, more adaptable solution for today’s orthopedic challenges,” said Mark McMahan, Vice President, Trauma & Extremities Marketing for Smith+Nephew.

Related Links:
Smith+Nephew


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
New
Electric Bed
DIXION Intensive Care Bed
New
High-Precision QA Tool
DEXA Phantom
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The skin-like sensor monitors internal and external body movement, and electrical signals (Photo courtesy of Huanyu “Larry” Cheng and Jennifer M. McCann)

Skin-Like Sensor Monitors Vital Signs and Tracks Healing After Surgery

Medical conditions such as bladder control issues and the need for monitoring vital signs after surgery require precise, long-term tracking to improve patient outcomes. These conditions can be challenging... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.